| Akantior |
Human |
polihexanide |
Polihexanide |
EMEA/H/C/005858 |
SIFI SPA |
2024/08/22
|
Authorised |
| Adzynma |
Human |
rADAMTS13 |
rADAMTS13 |
EMEA/H/C/006198 |
Takeda Manufacturing Austria AG |
2024/08/01
|
Authorised |
| GalliaPharm |
Human |
gallium (68Ga) chloride;germanium (68Ge) chloride |
gallium (68Ga) chloride;germanium (68Ge) chloride |
EMEA/H/C/006053 |
Eckert & Ziegler Radiopharma GmbH |
2024/08/01
|
Authorised |
| Dasatinib Accord Healthcare |
Human |
dasatinib |
Dasatinib monohydrate |
EMEA/H/C/006251 |
Accord Healthcare S.L.U. |
2024/07/26
|
Authorised |
| Avzivi |
Human |
bevacizumab |
bevacizumab |
EMEA/H/C/005574 |
FGK Representative Service GmbH |
2024/07/26
|
Authorised |
| Pomalidomide Accord |
Human |
pomalidomide |
Pomalidomide |
EMEA/H/C/006273 |
Accord Healthcare S.L.U. |
2024/07/26
|
Authorised |
| Cejemly |
Human |
sugemalimab |
sugemalimab |
EMEA/H/C/006088 |
Cstone Pharmaceuticals Ireland Limited |
2024/07/24
|
Authorised |
| Zegalogue |
Human |
dasiglucagon |
dasiglucagon hydrochloride |
EMEA/H/C/006214 |
Zealand Pharma A/S |
2024/07/24
|
Authorised |
| Pomalidomide Krka |
Human |
pomalidomide |
Pomalidomide |
EMEA/H/C/006314 |
Krka, d.d., Novo mesto |
2024/07/24
|
Authorised |
| Apexelsin |
Human |
paclitaxel |
paclitaxel |
EMEA/H/C/005997 |
Whiteoak Pharmaceutical B.V. |
2024/07/24
|
Authorised |
| Beqvez (previously Durveqtix) |
Human |
fidanacogene elaparvovec |
fidanacogene elaparvovec |
EMEA/H/C/004774 |
Pfizer Europe MA EEIG |
2024/07/24
|
Withdrawn |
| Pomalidomide Zentiva |
Human |
pomalidomide |
Pomalidomide |
EMEA/H/C/006294 |
Zentiva, k.s. |
2024/07/24
|
Authorised |
| Ixchiq |
Human |
Chikungunya vaccine (live) |
Chikungunya virus, strain CHIKV LR2006-OPY1, live attenuated |
EMEA/H/C/005797 |
Valneva Austria GmbH |
2024/06/28
|
Authorised |
| Eribulin Baxter |
Human |
eribulin |
Eribulin mesylate |
EMEA/H/C/006191 |
Baxter Holding B.V. |
2024/06/27
|
Authorised |
| Obgemsa |
Human |
vibegron |
vibegron |
EMEA/H/C/005957 |
Pierre Fabre Medicament |
2024/06/27
|
Authorised |
| Wezenla |
Human |
ustekinumab |
ustekinumab |
EMEA/H/C/006132 |
Amgen Technology (Ireland) UC |
2024/06/20
|
Authorised |
| Tocilizumab STADA (previously Tofidence) |
Human |
tocilizumab |
tocilizumab |
EMEA/H/C/005984 |
STADA Arzneimittel AG |
2024/06/20
|
Authorised |
| Fruzaqla |
Human |
fruquintinib |
fruquintinib |
EMEA/H/C/005979 |
Takeda Pharmaceuticals International AG Ireland |
2024/06/20
|
Authorised |
| Truqap |
Human |
capivasertib |
capivasertib |
EMEA/H/C/006017 |
AstraZeneca AB |
2024/06/17
|
Authorised |
| Altuvoct |
Human |
efanesoctocog alfa |
Efanesoctocog alfa |
EMEA/H/C/005968 |
Swedish Orphan Biovitrum AB (publ) |
2024/06/17
|
Authorised |